Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
Open Access
- 1 January 2014
- journal article
- research article
- Published by Hindawi Limited in Schizophrenia Research and Treatment
- Vol. 2014, 1-10
- https://doi.org/10.1155/2014/719395
Abstract
Objective. It has been suggested that atypical antipsychotics confer their effects via brain-derived neurotrophic factor (BDNF). We investigated the effect of quetiapine on serum levels of BDNF and vascular endothelial growth factor (VEGF) in drug-naive first-episode psychosis subjects.Methods. Fifteen patients drawn from a larger study received quetiapine treatment for twelve weeks. Baseline levels of serum BDNF and VEGF were compared to age- and sex-matched healthy controls and to levels following treatment. Linear regression analyses were performed to determine the relationship of BDNF and VEGF levels with outcome measures at baseline and week 12.Results. The mean serum BDNF level was significantly higher at week 12 compared to baseline and correlated with reductions in Brief Psychiatric Rating Scale (BPRS) and general psychopathology scores. Changes in serum VEGF levels also correlated significantly with a reduction in BPRS scores, a significant improvement in PANNS positive symptoms scores, and displayed a positive relationship with changes in BDNF levels.Conclusions. Our findings suggest that BDNF and VEGF are potential biomarkers for gauging improvement of psychotic symptoms. This suggests a novel neurotrophic-based mechanism of the drug effects of quetiapine on psychosis. This is the first report of VEGF perturbation in psychosis.Keywords
Funding Information
- AstraZeneca
This publication has 90 references indexed in Scilit:
- Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depressionBehavioural Brain Research, 2012
- The role of BDNF in the pathophysiology and treatment of schizophreniaJournal of Psychiatric Research, 2012
- Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disordersJournal of Psychiatry and Neuroscience, 2011
- Decreased BDNF in patients with antipsychotic naïve first episode schizophreniaSchizophrenia Research, 2010
- Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjectsBMC Psychiatry, 2009
- Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus MorphologyBiological Psychiatry, 2008
- BDNF Val66Met variant and age of onset in schizophreniaNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2008
- Association Between Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism and Progressive Brain Volume Changes in SchizophreniaAmerican Journal of Psychiatry, 2007
- Brain derived neurotropic factor in first-episode psychosisSchizophrenia Research, 2007
- Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy VolunteersArchives of General Psychiatry, 2006